Stocks · News reference

Barclays Maintains Overweight on Oscar Health, Raises Price Target to $49

Sep 17, 2026, 12:19 PMBenzinga Newsdesk

Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the price target from $39 to $49.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

The Motley FoolSep 25, 2026, 3:30 PMNeil Rozenbaum
Prediction: These 4 Stocks Could Double From Here
An investment analyst highlights four overlooked stocks with potential to double in value: Broadcom, Nu Holdings, Oscar Health, and Voyager Technologies. The article suggests these companies are flying under most investors' radar despite favorable fundamentals.
AVGO NU OSCR VOYG
BenzingaSep 22, 2026, 1:10 PMBenzinga Newsdesk
'Vance-Led Task Force Set to Remove 760,000 Allegedly Fraudulent Obamacare Enrollments' - WSJ Exclusive
https://www.wsj.com/politics/policy/vance-led-task-force-set-to-remove-760-000-allegedly-fraudulent-obamacare-enrollments-0fbb72d7
CNC CVS ELV MOH OSCR
BenzingaSep 18, 2026, 12:09 PMBenzinga Newsdesk
Raymond James Maintains Outperform on Oscar Health, Raises Price Target to $42
Raymond James analyst John Ransom maintains Oscar Health (NYSE:OSCR) with a Outperform and raises the price target from $34 to $42.
OSCR
BenzingaSep 17, 2026, 7:59 PMBenzinga Newsdesk
OSCR stock has given up its prior gain. Oscar Health shares were trading higher after Barclays and Baird raised their respective price targets on the stock.
OSCR